Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rejuve Meds vs Wisp

Rejuve Meds
Graded #208

Higher grade

vs+1.6999999999999886
Wisp
Graded #243

Lower grade

The verdict

Rejuve Meds takes it — 66.1/100 to 64.4/100, but only just.

Rejuve Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no… Wisp is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRejuve Meds +15
65
50
Dose & formulationWisp +12
64
76
Clinical oversightWisp +3
79
82
Labs & monitoringWisp +1
52
53
FulfillmentRejuve Meds +5
71
66
Contract termsRejuve Meds +6
61
55
Rejuve Meds · left barWisp · right bar

The numbers

MetricRejuve MedsWisp
WeighScore66.1/10064.4/100
GradeCC
Scorecard rank#208#243
Semaglutide$165/mo (starting dose, compounded)$225/mo (compounded oral)
Tirzepatide$265/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Rejuve Meds

Graded #208 · C

Strengths

  • Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
  • No membership fees — everything is included; free shipping
  • HSA/FSA eligible; intro pricing from $85 for the first month
  • Doctor-guided programs with personalized care
  • Names a "Rejuve Meds Pharmacy Network" for fulfillment

Where it loses points

  • Individual compounding pharmacies not named (only a "pharmacy network")
  • Prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard